As Lipitor Lawsuits Mount, Bernstein Liebhard LLP Notes Studies Suggesting Experimental Cholesterol

The Firm is investigating Lipitor lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin. New York, New York (PRWEB) April 01, 2014 As Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) filed on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin continue to mount in federal court, Bernstein Liebhard LLP notes the release of two new studies which suggest that an experimental cholesterol-lowering drug currently in development could become an alternative to sta
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories